236 related articles for article (PubMed ID: 7911549)
1. [Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field].
González-Manzano R
Med Clin (Barc); 1994 Apr; 102(13):506-15. PubMed ID: 7911549
[No Abstract] [Full Text] [Related]
2. Multiple drug resistance in cancer therapy.
Schneider E; Cowan KH
Med J Aust; 1994 Mar; 160(6):371-3. PubMed ID: 7907772
[No Abstract] [Full Text] [Related]
3. [Glycoprotein P and resistance to antitumor chemotherapy].
Vicente P; Bellmunt J; de Torres I
Med Clin (Barc); 1993 Dec; 101(20):785-8. PubMed ID: 7906748
[No Abstract] [Full Text] [Related]
4. [Glycoprotein in multidrug-resistant malignancies--clinical implications].
Ellis A; Lishner M; Manor J; Ravid M
Harefuah; 1994 Mar; 126(6):334-7. PubMed ID: 7910806
[No Abstract] [Full Text] [Related]
5. [Resistance to anticancer drugs. Some strong tendencies in current research].
Robert J; Barra Y; Riou JF
Bull Cancer; 1992; 79(11):1025-30. PubMed ID: 1363832
[No Abstract] [Full Text] [Related]
6. [Perspectives on modulation of chemoresistance of malignant diseases].
Allerödder HP; Ukena D; Sybrecht GW
Pneumologie; 1993 Sep; 47(9):513-7. PubMed ID: 7901849
[No Abstract] [Full Text] [Related]
7. Multidrug resistance.
Moscow JA; Cowan KH
Cancer Chemother Biol Response Modif; 1991; 12():91-109. PubMed ID: 1681846
[No Abstract] [Full Text] [Related]
8. [Methods for studying pleiotropic drug resistance (multidrug resistance, MDR)].
Gobbi M; Michieli M; Raspadori D; Damiani D; Michelutti A; Pierri I; Tazzari PL
Haematologica; 1991 Jun; 76 Suppl 3():150-3. PubMed ID: 1684338
[No Abstract] [Full Text] [Related]
9. [Multidrug resistance in hematological malignancies: prognostic significance and the effect of resistance-modulating drugs].
Sonneveld P; te Boekhorst PA
Ned Tijdschr Geneeskd; 1994 Mar; 138(10):508-12. PubMed ID: 7908127
[No Abstract] [Full Text] [Related]
10. [GP-170 glycoprotein and resistance to chemotherapy].
Lazarowski AJ
Medicina (B Aires); 1991; 51(3):279-80. PubMed ID: 1687986
[No Abstract] [Full Text] [Related]
11. The multidrug resistance phenotype in human cancer.
Cordon-Cardo C; O'Brien JP
Important Adv Oncol; 1991; ():19-38. PubMed ID: 1678363
[No Abstract] [Full Text] [Related]
12. [Role of multi-drug resistance in genito-urinary tumors].
Theyer G; Hamilton G
Prog Urol; 1993 Jun; 3(3):385-92; discussion 392-3. PubMed ID: 8103698
[No Abstract] [Full Text] [Related]
13. Multidrug resistance mediated by P-glycoprotein in haematological malignancies.
Pasman PC; Schouten HC
Neth J Med; 1993 Jun; 42(5-6):218-31. PubMed ID: 8104318
[TBL] [Abstract][Full Text] [Related]
14. Resistance to natural products in leukemia.
Borst P; Baas F; Lincke CR; Schinkel AH; Smit JJ; Van der Velde-Koerts T
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():44-7. PubMed ID: 1975205
[No Abstract] [Full Text] [Related]
15. P-glycoprotein-mediated multidrug resistance and cytotoxic effector cells.
Savas B; Cole SP; Akoglu TF; Pross HF
Nat Immun; 1992; 11(4):177-92. PubMed ID: 1358293
[TBL] [Abstract][Full Text] [Related]
16. [Multidrug resistance].
Baccarani M
Haematologica; 1991 Jun; 76 Suppl 3():145-9. PubMed ID: 1684337
[No Abstract] [Full Text] [Related]
17. [Multiple drug resistance: current concepts and future perspectives].
Salud A; Porcel JM
Rev Clin Esp; 1993 May; 192(9):447-50. PubMed ID: 8100082
[No Abstract] [Full Text] [Related]
18. Multidrug resistance in human cancer.
Goldstein LJ; Pastan I; Gottesman MM
Crit Rev Oncol Hematol; 1992; 12(3):243-53. PubMed ID: 1353966
[No Abstract] [Full Text] [Related]
19. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
Kaye SB
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein in adult solid tumors. Expression and prognostic significance.
Leighton JC; Goldstein LJ
Hematol Oncol Clin North Am; 1995 Apr; 9(2):251-73. PubMed ID: 7642464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
